Status:
COMPLETED
Resistance on Antithrombotic Drugs in Ischemic Heart Disease
Lead Sponsor:
University of Zagreb
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
Brief Summary
The purpose of this study is to determine whether aspirin and clopidogrel resistance measured with Multiplate function analyser has a good correlation with incidence of major adverse cardiac events in...
Detailed Description
Our plan is to enroll 180 patients with diagnosed CAD who electively undergo percutaneous coronary intervention (PCI). Blood samples will be taken just before the procedure and one day after the proce...
Eligibility Criteria
Inclusion
- Elective PCI
- \> 7 days on aspirin 100mg therapy before the intervention
- \> 7 days on clopidogrel 75mg therapy before the intervention
Exclusion
- Loading dose of clopidogrel
- \< 7 days on aspirin therapy before the intervention
- Myocardial infarction less than 30 days before the intervention
- Cerebrovascular incident less that three months before the intervention
- Haemorrhagic diathesis
- Trc \< 100
- Htc \< 30%
- Creatinine \> 140
Key Trial Info
Start Date :
February 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
141 Patients enrolled
Trial Details
Trial ID
NCT00742430
Start Date
February 1 2009
End Date
August 1 2011
Last Update
February 14 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinic of Cardiovascular Diseases, Clinical Medical Centre Rebro
Zagreb, Croatia, 10000